Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 12/20 | 0.56 |
| ▸ | TERT | O14746 | 2/20 | 0.56 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | STAT6 | P42226 | 1/20 | 0.50 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.50 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12127001 | 0.87 | TERT (0.71) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30272534 | 0.86 | TERT (0.59) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL12225934 | 0.83 | TERT (0.66) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL7648035 | 0.81 | POLB (0.59) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL21988071 | 0.81 | POLB (0.59) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL24401821 | 0.79 | STAT3 (0.73) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL12869513 | 0.79 | CYP1B1 (0.55) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL12133952 | 0.78 | POLB (0.85) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL1105127 | 0.77 | TERT (0.69) | POLBMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL20419197 | 0.76 | CYP1B1 (0.78) | POLBMEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741487-B2 | Method for producing quaterrylene-3,4:13, 14-tetracarboxy diimides by direct synthesis | BASF AKTIENGESELLSCHAFT (DE) | 2010-06-22 | — | — | US | disclosed |
| US-20090030206-A1 | METHOD FOR PRODUCING QUATERRYLENE-3,4:13, 14-TETRACARBOXY DIIMIDES BY DIRECT SYNTHESIS | BASF AKTIENGESELLSCHAFT (DE) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030206-A1 | METHOD FOR PRODUCING QUATERRYLENE-3,4:13, 14-TETRACARBOXY DIIMIDES BY DIRECT SYNTHESIS | CDY1; CDY1B, C9, HACL2 | POLB 1276/4885MEN1 851/4885KMT2A 807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.